SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-073109
Filing Date
2023-12-26
Accepted
2023-12-26 18:10:19
Documents
2
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1546
2 EX-24 ngne-ex24.htm EX-24 10308
  Complete submission text file 0000950170-23-073109.txt   13561
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address
Woods Robert Keith (Reporting) CIK: 0001995131 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36327 | Film No.: 231514319